Lindbrook Capital’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$491 Sell
33
-128
-80% -$2.2K ﹤0.01% 2623
2024
Q4
$2.92K Buy
+161
New +$2.17K ﹤0.01% 2189
2024
Q3
Sell
-32
Closed -$443 2834
2024
Q2
$443 Buy
+32
New +$507 ﹤0.01% 2649
2024
Q1
Sell
-83
Closed -$1.88K 2664
2023
Q4
$1.88K Hold
83
﹤0.01% 2282
2023
Q3
$2.06K Hold
83
﹤0.01% 2117
2023
Q2
$2.33K Hold
83
﹤0.01% 2096
2023
Q1
$1.85K Hold
83
﹤0.01% 2279
2022
Q4
$2.21K Hold
83
﹤0.01% 2190
2022
Q3
$2K Hold
83
﹤0.01% 2013
2022
Q2
$2K Sell
83
-104
-56% -$1.95K ﹤0.01% 1922
2022
Q1
$4K Buy
+187
New +$4.06K ﹤0.01% 1678

Other funds holding CCRN

Lindbrook Capital's CCRN Position: Q1 2025 in Review

Lindbrook Capital reduced its Cross Country Healthcare (CCRN) stake by 80% in Q1 2025, selling an estimated $2.2K and leaving 33 shares worth $491. The position accounts for ﹤0.01% of the portfolio, ranked #2623.

Lindbrook Capital first reported a position in CCRN in Q1 2022 and has held it in 11 quarters since. The position peaked at $4K in Q1 2022. 161 funds tracked by Wall St. Rank hold CCRN as of Q1 2025.

  • Lindbrook Capital held 33 shares of Cross Country Healthcare worth $491 as of Q1 2025.
  • Lindbrook Capital sold 128 Cross Country Healthcare shares in Q1 2025, an estimated $2.2K.
  • Cross Country Healthcare made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2623 holding.
  • Lindbrook Capital first reported a position in Cross Country Healthcare in Q1 2022 and has held it in 11 quarters since.
  • Lindbrook Capital's Cross Country Healthcare position peaked at $4K in Q1 2022.
  • 161 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.